N. Ossei-Gerning

T. Kinnaird, N. Ossei-Gerning, Richard A Anderson, 2014, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Association of the platelet Pl(A) polymorphism of glycoprotein IIb/IIIa and the fibrinogen Bbeta 448 polymorphism with myocardial infarction and extent of coronary artery disease.

A. Carter, N. Ossei-Gerning, P. Grant, 1997, Circulation.

Association of Factor VII:C Levels with Environmental and Genetic Factors in Patients with Ischaemic Heart Disease and Coronary Atheroma Characterised by Angiography

N. Ossei-Gerning, P. Grant, D. Heywood, 1996, Thrombosis and Haemostasis.

Sex Differences in Coagulation and Fibrinolysis in Subjects with Coronary Artery Disease

N. Ossei-Gerning, P. Grant, I. Wilson, 1998, Thrombosis and Haemostasis.

Vascular Access Site and Outcomes Among 26,807 Chronic Total Coronary Occlusion Angioplasty Cases From the British Cardiovascular Interventions Society National Database.

M. Mamas, T. Kinnaird, P. Ludman, 2017, JACC. Cardiovascular interventions.

Switching from transfemoral to transradial access for PCI: a single-center learning curve over 5 years.

A. Zaman, T. Kinnaird, N. Ossei-Gerning, 2014, The Journal of invasive cardiology.

Erectile dysfunction: a window to the heart

N. Ossei-Gerning, N. Pugh, A. Wood, 2015, BMJ Case Reports.

Dietary Nitrate Supplementation Reduces Circulating Platelet-Derived Extracellular Vesicles in Coronary Artery Disease Patients on Clopidogrel Therapy: A Randomised, Double-Blind, Placebo-Controlled Study

F. Abdul, N. Ossei-Gerning, Richard A Anderson, 2018, Thrombosis and Haemostasis.

25 Patients treated with long term warfarin therapy undergoing PCI – complex disease and adverse outcomes

T. Kinnaird, Khaled Yazji, N. Ossei-Gerning, 2016, Heart.

Insulin receptor substrate-1 gene polymorphism and cardiovascular risk in non-insulin dependent diabetes mellitus and patients undergoing coronary angiography.

N. Ossei-Gerning, P. Grant, M. Mansfield, 1997, Clinical and laboratory haematology.

Risk classification in primary prevention of CVD according to QRISK2 and JBS3 ‘heart age’, and prevalence of elevated high-sensitivity C reactive protein in the UK cohort of the EURIKA study

J. Medina, N. Ossei-Gerning, J. Halcox, 2018, Open Heart.

Extended duration of brachially inserted intra-aortic balloon pump for myocardial protection in two patients undergoing urgent coronary artery bypass grafting.

N. Ossei-Gerning, H. Luckraz, S. Bundhoo, 2008, Interactive cardiovascular and thoracic surgery.

Routine iso-osmolar contrast media use and acute kidney injury following percutaneous coronary intervention for ST elevation myocardial infarction.

T. Kinnaird, S. Gallagher, N. Ossei-Gerning, 2019, Minerva cardioangiologica.

The paraoxonase Gln‐Arg 192 polymorphism in subjects with ischaemic heart disease

N. Ossei-Gerning, P. Grant, M. Stickland, 1997, Coronary artery disease.

Comparison of the Effects of Incomplete Revascularization on 12-Month Mortality in Patients <80 Compared With ≥80 Years Who Underwent Percutaneous Coronary Intervention.

M. Mamas, T. Kinnaird, F. Abdul, 2016, American Journal of Cardiology.

Intractable ventricular fibrillation: post ascending aortic dissection repair.

N. Ossei-Gerning, Ashish H. Shah, 2014, Cardiovascular revascularization medicine : including molecular interventions.

Detection of a common polymorphism in the angiotensin-1 converting enzyme (ACE) gene promoter

J. Barrett, N. Ossei-Gerning, P. Grant, 1995 .

Vascular Health and Risk Management Dovepress Rivaroxaban in Patients with a Recent Acute Coronary Syndrome Event: Integration of Trial Findings into Clinical Practice

N. Ossei-Gerning, Ganesh Nallur, Shivu, 2022 .